ono 1078 has been researched along with Drug Withdrawal Symptoms in 2 studies
pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tamaoki, J | 1 |
Kondo, M | 1 |
Sakai, N | 1 |
Nakata, J | 1 |
Takemura, H | 1 |
Nagai, A | 1 |
Takizawa, T | 1 |
Konno, K | 1 |
Kinoshita, M | 1 |
Shiraishi, T | 1 |
Koga, T | 1 |
Ayabe, M | 1 |
Rikimaru, T | 1 |
Oizumi, K | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Fractional Concentration of Exhaled NO(FeNO) to Direct The Treatment of Sub-acute Cough:A Prospective, Open Label, Randomized and Placebo-Controlled Trial[NCT02655562] | Phase 4 | 200 participants (Anticipated) | Interventional | 2016-04-30 | Suspended (stopped due to There are difficulties in recruiting patients) | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for ono 1078 and Drug Withdrawal Symptoms
Article | Year |
---|---|
Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Anti-Asthmatic Agents; Asthma; Beclomethasone; | 1997 |
1 other study available for ono 1078 and Drug Withdrawal Symptoms
Article | Year |
---|---|
Churg-Strauss syndrome after corticosteroid withdrawal in an asthmatic patient treated with pranlukast.
Topics: Anti-Asthmatic Agents; Asthma; Chromones; Churg-Strauss Syndrome; Female; Humans; Leukotriene Antago | 1999 |